Building A Successful Clinical Trial Engagement Platform

A Clinical Trial Engagement Platform creates a single destination for patients to view all of a sponsor’s clinical trials, but its value is so much greater than that. From education about clinical research to resources that help ease common concerns, a clinical trial engagement platform will transform the way sponsors connect with patients – all while gaining significant cost efficiencies, generating opportunities to communicate with scale, and enabling sponsors to positively interact with a diverse audience.

This webinar will illustrate why a clinical trial engagement platform is a critical asset for sponsors. Citing original research conducted with a diverse group of patients who have searched for clinical trials online, we will explore what kind of content patients say influences them to learn more, and what motivates them to participate in clinical research. These areas of content and, importantly, acknowledgement of patients’ health literacy levels, are vital to making your Clinical Trial Engagement Platform successful and will be shared throughout this webinar. We will also outline the components of a successful clinical trial engagement platform, including clinical-trial-finder search functionality, and provide a roadmap for how to execute this important project.

Why is a clinical trial engagement platform important, and how can you develop a successful one? Beyond helping connect patients to trials they may qualify for, creating such a platform allows sponsors to provide much-needed education about clinical trials, directly address issues that can impact participant diversity, create a database of patients who show interest and would like to be informed about future trials, engage HCPs, and much more.

Building a useful clinical trial engagement platform also generates a host of efficiencies: once the infrastructure is in place, it’s easy to add new trials and update the status of existing trials; pre-screeners or collection forms can be integrated, turning the website into a vehicle to drive patient recruitment; and elevating clinical trials from a link at the bottom of a corporate page (if even that) helps build brand equity.

Register for this webinar to hear from leading sponsors who have developed their own clinical trial engagement platforms: why they created them, the value they bring to their company, and best practices for implementation.

Speakers

Pamela Landau, Senior Vice President of Integrated Solutions, Continuum Clinical

Pamela Landau has more than 20 years of experience in global marketing strategy and leadership experience, with 10+ years specific to healthcare, technology and communications. As Senior Vice President of Integrated Solutions, Pamela combines her experience in direct marketing with insights-driven, patient-centric strategy to help connect patients to promising new therapies, as well as to help accelerate clinical trials and drug development. She applies her passion for patient engagement and thorough understanding of the patient’s lived experience and unmet needs to every recruitment program.

Message Presenter

Yulia Urfer, Clinical Operations Manager, Debiopharm International

As a Clinical Operations Manager, Yulia Urfer is leading a team in charge of clinical trials from set-up to close-out. She ensures sponsor oversight, operational excellence and study conduct according to industry standards and in-house processes. Yulia’s expertise lies in the development and implementation of novel recruitment strategies for oncology clinical trials, including the clinical trials with complex/difficult enrollment,  with a focus on patient engagement.

Message Presenter

Kelly White, Head of Global Trial Optimization: Oncology, Merck

Kelly White leads the Merck Oncology feasibility and trial optimization function. She has a track record of data driven problem solving and execution planning success. She has continued to evolve and expand the strategic approach of her team and draws on her prior experience in clinical nursing, academic and community based clinical research practice. She has a unique focus on both patient and site experience in oncology clinical trial participation and has significant experience in deploying novel and strategic initiatives to support these critical stakeholders.

Message Presenter

Sara Pierson, Director of Patient Recruitment Programs, Pfizer

Sara Pierson is Director, Patient Recruitment Programs at Pfizer where she oversees the recruitment strategies for Internal Medicine and Oncology clinical trials.  Sara is also co-leading the development, implementation, and expansion of PfizerClinicalTrials.com, an end-to-end participant centered platform.  She brings over 15 years of industry experience in patient recruitment, engagement, and retention across vendor, CRO, and sponsor organizations.

Message Presenter

Gwenn Oakes, Associate Director of Global Trial Optimization, Merck

Gwenn Oakes is an Associate Director for Merck’s Global Trial Optimization team which supports feasibility, planning, and recruitment and retention support on behalf of Clinical Trial Operations. Beginning her career in patient recruitment of pediatric clinical trials, she has a passion for ensuring patient access to clinical trial information. Since 2013, Gwenn has supported the oncology portfolio at Merck through the creation and expansion of Keynote Clinical Trial program and content and branding across MerckOncologyClinicalTrials.com.

Message Presenter